Europe (EU/UK): Extended patent terms and regulatory data exclusivity protect semaglutide until the early 2030s
Based on early-phase clinical trial data, retatrutide has an estimated half-life of approximately six days, supporting once-weekly subcutaneous dosing
The LIRA-RENAL Trial (Once-Daily Liraglutide) The Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL) trial investigated the efficacy and safety of liraglutide as an add-on to existing glucose-lowering medications in people with inadequately controlled T2DM and moderate renal impairment (stage 3 CKD, eGFR 3059 ml/min/1.73 m 2 ) [48]
Sugary foods that used to be forgiven by faster digestion now sit in the stomach and cause reflux
(Phase 3 program across 13 countries, over 5,800 participants.) [PubMed] Eli Lilly and Company
Unlike its predecessors, this compound activates three distinct receptor pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
